Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Greg
    Member
    • Oct 2009
    • 31

    #1

    Cuffdiff NOTEST for splicing.diff

    Using the tophat/cufflinks combo to find differential alternative splicing.

    The cuffdiff manual says that if there "not enough alignments for testing" then you will get NOTEST and the treatments will not be compared. Does anyone have an idea as to what the cutoff for this is? Many of the genes that get NOTEST in my data set (single end) have a large number of reads (several hundred). Could it be because of insufficient coverage? or maybe operator error?

    thanks!
  • Greg
    Member
    • Oct 2009
    • 31

    #2
    So I just found the -c option to set the number of required reads. It does change the number of tests that happen but there are still less then I would think. Any ideas? What are the other criteria for doing the test or not? Would more info on my workflow be helpful?

    Comment

    • griffon42
      Member
      • Jan 2009
      • 23

      #3
      I'm experiencing the same issue. I'm using cufflinks 0.8.3 (the 7/2 release) and the -c option doesn't seem to work as described in the manual. As extreme examples, I have loci that are "OK" for stat testing and "yes" for significant but have only 2 reads vs. 0 reads across samples.

      As mentioned, changing -c DOES affect the number of loci tested, but not by much and it does not fix situations like that described above.

      Does anyone know how to manage this situation? The differential expression output files i'm generating are rather unmanageable.

      Thanks.

      Comment

      • jetspeeder
        Member
        • Jun 2010
        • 12

        #4
        I have a lot of NOTEST and FAIL as well,

        Also do you guys know the significance of this and why the percentages are high for missed and wrong exons and what the signifies? Thanks.

        #> Genomic sequence: chr1
        # Query mRNAs : 20972 in 20055 loci (3356 multi-exon transcripts)
        # (633 multi-transcript loci, ~1.0 transcripts per locus)
        # Reference mRNAs : 1024 in 912 loci (966 multi-exon)
        # Corresponding super-loci: 695
        #--------------------| Sn | Sp | fSn | fSp
        Base level: 63.4 16.4 - -
        Exon level: 37.6 9.6 44.0 11.3
        Intron level: 52.6 31.5 53.4 31.9
        Intron chain level: 18.6 5.4 24.7 7.1
        Transcript level: 0.0 0.0 0.1 0.0
        Locus level: 19.5 0.9 22.9 1.0
        Missed exons: 2554/8302 ( 30.8%)
        Wrong exons: 26036/32327 ( 80.5%)
        Missed introns: 3161/7289 ( 43.4%)
        Wrong introns: 7825/12186 ( 64.2%)
        Missed loci: 208/912 ( 22.8%)
        Wrong loci: 17823/20055 ( 88.9%)

        Comment

        • Greg
          Member
          • Oct 2009
          • 31

          #5
          I've had the same experience. Could only guess...

          Comment

          • SEQond
            Member
            • Jul 2010
            • 27

            #6
            So anyone has an idea on how to find the ideal -c "minimum number of alignments in a locus for needed to conduct significance testing" (--min-alignment-count) ?

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            19 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            26 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-13-2026, 09:56 AM
            0 responses
            22 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            28 views
            0 reactions
            Last Post SEQadmin2  
            Working...